Ming Hui Lee

2.4k total citations
17 papers, 527 citations indexed

About

Ming Hui Lee is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Ming Hui Lee has authored 17 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Ming Hui Lee's work include Liver Disease Diagnosis and Treatment (3 papers), Diet, Metabolism, and Disease (3 papers) and Insect and Pesticide Research (2 papers). Ming Hui Lee is often cited by papers focused on Liver Disease Diagnosis and Treatment (3 papers), Diet, Metabolism, and Disease (3 papers) and Insect and Pesticide Research (2 papers). Ming Hui Lee collaborates with scholars based in Singapore, South Korea and New Zealand. Ming Hui Lee's co-authors include Cheng Han Ng, Yip Han Chin, Chin Meng Khoo, Gangadhara Sundar, Samantha Peiling Yang, Zhi‐Qiang Zhang, Patrick Tan, Jeffery Wei Heng Koh, Jeanie Wu and Mark Muthiah and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Cancer Research.

In The Last Decade

Ming Hui Lee

16 papers receiving 520 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming Hui Lee Singapore 12 168 160 127 88 86 17 527
Michal Beránek Czechia 13 131 0.8× 63 0.4× 52 0.4× 22 0.3× 152 1.8× 18 457
Masayo Kimura Japan 14 308 1.8× 21 0.1× 38 0.3× 160 1.8× 82 1.0× 35 704
Amel Benammar-Elgaaïed Tunisia 17 184 1.1× 62 0.4× 23 0.2× 44 0.5× 61 0.7× 44 583
Michalina Dąbrowska Poland 15 303 1.8× 77 0.5× 53 0.4× 57 0.6× 143 1.7× 48 611
Raymon Vijzelaar Netherlands 13 389 2.3× 46 0.3× 26 0.2× 88 1.0× 67 0.8× 29 652
Lidan Xu China 15 234 1.4× 65 0.4× 32 0.3× 39 0.4× 67 0.8× 48 477
Satoru Komaki Japan 12 154 0.9× 38 0.2× 22 0.2× 54 0.6× 29 0.3× 35 394
Stewart Lake Australia 15 156 0.9× 77 0.5× 21 0.2× 40 0.5× 40 0.5× 41 623
Cheng‐Chin Wu Taiwan 14 180 1.1× 55 0.3× 16 0.1× 50 0.6× 62 0.7× 38 619
Cheuk Wun Li United States 12 128 0.8× 97 0.6× 383 3.0× 40 0.5× 28 0.3× 15 690

Countries citing papers authored by Ming Hui Lee

Since Specialization
Citations

This map shows the geographic impact of Ming Hui Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Hui Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Hui Lee more than expected).

Fields of papers citing papers by Ming Hui Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Hui Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Hui Lee. The network helps show where Ming Hui Lee may publish in the future.

Co-authorship network of co-authors of Ming Hui Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Hui Lee. A scholar is included among the top collaborators of Ming Hui Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Hui Lee. Ming Hui Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
An, Ömer, Yangyang Song, Xinyu Ke, et al.. (2021). “3G” Trial: An RNA Editing Signature to Guide Gastric Cancer Chemotherapy. Cancer Research. 81(10). 2788–2798. 13 indexed citations
2.
Ng, Cheng Han, Snow Yunni Lin, Yip Han Chin, et al.. (2021). Antidiabetic Medications for Type 2 Diabetics with Nonalcoholic Fatty Liver Disease: Evidence From a Network Meta-Analysis of Randomized Controlled Trials. Endocrine Practice. 28(2). 223–230. 30 indexed citations
3.
Lee, Ming Hui, Jeffery Wei Heng Koh, Cheng Han Ng, et al.. (2021). A meta-analysis of clinical manifestations in asian systemic lupus erythematous: The effects of ancestry, ethnicity and gender. Seminars in Arthritis and Rheumatism. 52. 151932–151932. 10 indexed citations
4.
Chin, Yip Han, Sneha Rajiv Jain, Ming Hui Lee, et al.. (2021). Small bowel adenocarcinoma in Crohn’s disease: a systematic review and meta-analysis of the prevalence, manifestation, histopathology, and outcomes. International Journal of Colorectal Disease. 37(1). 239–250. 12 indexed citations
5.
Wong, Chloe, Ming Hui Lee, Clyve Yu Leon Yaow, et al.. (2021). Glucagon-Like Peptide-1 Receptor Agonists for Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: A Meta-Analysis. Frontiers in Endocrinology. 12. 609110–609110. 62 indexed citations
6.
7.
Lee, Ming Hui, Yip Han Chin, Cheng Han Ng, et al.. (2020). Risk Factors of Thyroid Eye Disease. Endocrine Practice. 27(3). 245–253. 26 indexed citations
8.
9.
Chin, Yip Han, Cheng Han Ng, Ming Hui Lee, et al.. (2020). Prevalence of thyroid eye disease in Graves’ disease: A meta‐analysis and systematic review. Clinical Endocrinology. 93(4). 363–374. 118 indexed citations
10.
Sundar, Raghav, Alvin Wei Tian Ng, Hermioni Zouridis, et al.. (2019). DNA methylation signature predictive of benefit from neoadjuvant chemotherapy in esophageal adenocarcinoma: Results from the MRC OEO2 phase III trial.. Journal of Clinical Oncology. 37(4_suppl). 43–43.
11.
Lee, Ming Hui & Zhi‐Qiang Zhang. (2018). Assessing the augmentation of Amblydromalus limonicus with the supplementation of pollen, thread, and substrates to combat greenhouse whitefly populations. Scientific Reports. 8(1). 12189–12189. 18 indexed citations
12.
Yong, Wei Peng, Sun Young Rha, Iain Beehuat Tan, et al.. (2017). Microarray-based tumor molecular profiling to direct choice of cisplatin plus S-1 or oxaliplatin plus S-1 for advanced gastric cancer: A multicentre, prospective, proof-of-concept phase 2 trial.. Journal of Clinical Oncology. 35(4_suppl). 48–48. 2 indexed citations
13.
Lee, Ming Hui & Zhi‐Qiang Zhang. (2016). Habitat structure and its influence on populations of Amblydromalus limonicus (Acari: Phytoseiidae). Systematic and Applied Acarology. 21(10). 1361–1361. 11 indexed citations
14.
Lee, Ming Hui, et al.. (2015). Upregulated, 7q21–22 amplicon candidate gene SHFM1 confers oncogenic advantage by suppressing p53 function in gastric cancer. Cellular Signalling. 27(6). 1075–1086. 11 indexed citations
15.
Broët, Philippe, Cyril Dalmasso, Eng Huat Tan, et al.. (2011). Genomic Profiles Specific to Patient Ethnicity in Lung Adenocarcinoma. Clinical Cancer Research. 17(11). 3542–3550. 55 indexed citations
16.
Ganesan, Kumaresan, Tatiana Ivanova, Yonghui Wu, et al.. (2008). Inhibition of Gastric Cancer Invasion and Metastasis by PLA2G2A , a Novel β-Catenin/TCF Target Gene. Cancer Research. 68(11). 4277–4286. 88 indexed citations
17.
Huynh, Hung, Pierce K. H. Chow, Nallasivam Palanisamy, et al.. (2008). Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma. Journal of Hepatology. 49(1). 52–60. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michal Beránek Breakdown of academic impact, for papers by Masayo Kimura Breakdown of academic impact, for papers by Amel Benammar-Elgaaïed Breakdown of academic impact, for papers by Michalina Dąbrowska Breakdown of academic impact, for papers by Raymon Vijzelaar Breakdown of academic impact, for papers by Lidan Xu Breakdown of academic impact, for papers by Satoru Komaki Breakdown of academic impact, for papers by Stewart Lake Breakdown of academic impact, for papers by Cheng‐Chin Wu Breakdown of academic impact, for papers by Cheuk Wun Li
Rankless by CCL
2026